Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech
Who is this study for? Patients with progressive apraxia of speech
What treatments are being studied? AV-1451
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
The study is designed to determine the relationship between structural and functional changes in the brain on imaging and progression of speech and language, neurological and neuropsychological features in patients with neurodegenerative apraxia of speech (AOS).
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• We will study subjects that fulfill clinical inclusion criteria for neurodegenerative AOS that have been seen and diagnosed at Mayo Clinic
Locations
United States
Minnesota
Mayo Clinic
RECRUITING
Rochester
Contact Information
Primary
Sarah Boland, CCRP
boland.sarah@mayo.edu
507-284-3863
Time Frame
Start Date: 2018-07-01
Estimated Completion Date: 2028-06
Participants
Target number of participants: 50
Treatments
Experimental: Tau positron emission tomography (PET)
All subjects will receive Tau PET scan on approximately day 1 or day 2 of study to assess Tau burden in the brain.
Related Therapeutic Areas
Sponsors
Leads: Mayo Clinic
Collaborators: National Institute on Deafness and Other Communication Disorders (NIDCD)